Chronic Malignancies Working Party (CMWP)
Study number:
2005-001628-35
Type of transplant:
Short title:
MMVAR
Study status:
Completed Patient Recruitment
Deadline for data collection:
Study design:
Randomised, parallel-group, open-label, multicentre study
Primary objective:
the hypothesis that treatment with Velcade plus Thalidomide plus Dexamethasone in combination, will result in a longer time progrethe hypothesis that treatment with Velcade plus Thalidomide plus Dexamethasone in combination, will result in a longer time progression than Thalidomide plus Dexamethasone in subjects with relapsed or progressive myeloma after autologous transplanatation.
Key inclusion criteria:
>=18 years old
Country:
France
Belgium
Germany
Switzerland
Austria
Italy
Czech Republic
Hungary
Israel
United Kingdom
Principal investigator:
Laurent Garderet
Principal investigator email:
EBMT Study coordinator:
Marleen van Os